Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C.

Journal of digestive diseases - 1 Jan 2022

Al-Omary Ahmed, Byth Karen, Weltman Martin, George Jacob, Eslam Mohammed

Abstract excerpt

OBJECTIVES: Metabolic dysfunction-associated fatty liver disease (MAFLD) can develop in any patient, including those with chronic hepatitis C (CHC). The recently proposed diagnostic criteria for MAFLD provide a unique opportunity to investigate the impact of concomitant fatty liver in patients with another established cause for their liver disease. The objective of our study was to assess the characteristics and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatty Liver
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Non-alcoholic Fatty Liver Disease

Source

Identifiers

PMID: 34902220
DOI: 10.1111/1751-2980.13071

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C.PMID 34902220Read ↗

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity Read ↗

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunctionSemantic proximity Read ↗

The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.Semantic proximity Read ↗

MAFLD: an optimal framework for understanding liver cancer phenotypes.Semantic proximity Read ↗

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.Semantic proximity Read ↗

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.Semantic proximity Read ↗

The New Paradigm of Non-Alcoholic Fatty Liver Disease: Phenotypic Diversity of Metabolically Associated Fatty Liver DiseaseSemantic proximity Read ↗

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.Semantic proximity Read ↗

Prevalence Of Fatty Liver Disease And Associated Factors Among Outpatients At Muhas Academic Medical Centre,tanzaniaSemantic proximity Read ↗

Fatty liver in chronic hepatitis C infection: unravelling the mechanisms.Semantic proximity Read ↗

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.Semantic proximity Read ↗

A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.